Latest Data of InnoCares Novel BCL2 Inhibitor Presented at the 67th Annual Meeting of the American Society of Hematology (ASH)
December 08, 2025 21:04 ET | Source: InnoCare Pharma BEIJING, Dec. 08,…
Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients
Long-term OS follow-up analysis of JUPITER-02 demonstrates significantly better and clinically meaningful…
InnoCare Announces First Patient Dosed in the Global Phase II Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Prurigo Nodularis
BEIJING, Nov. 27, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE:…
Fangzhou Awarded Golden Bull Award for Leadership in AI-Powered Chronic Disease Management
XIAMEN, China, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or…
SERES Officially Listed on HKEX, Leveraging Dual “A+H” Capital Platforms to Power Global Expansion
CHONGQING, China, Nov. 6, 2025 /PRNewswire/ -- On November 5, SERES Group…
Fangzhous XingJie LLM Completes Key National Filing, Setting Stage for Further AI-Driven Chronic Care Innovations
SHENZHEN, China, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or…
Ascentage Pharma to Participate in Two Upcoming Investor Conferences in November 2025
October 29, 2025 20:00 ET | Source: ASCENTAGE PHARMA GROUP INTERNATIONAL ROCKVILLE,…
HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025
September 04, 2025 20:00 ET | Source: HUTCHMED (China) Limited HONG KONG…
NOAH Holdings | ARK Wealth H2 CIO Report: Technology-Driven Deflation and Efficiency Dividends Are Reshaping Asset Allocation
The Report explores a dual-track economic structure, balancing structural inflation with deep…
HUTCHMED to Announce 2025 Half-Year Financial Results
July 03, 2025 04:30 ET | Source: HUTCHMED (China) Limited HONG KONG…